offline
Tandem (TNDM) Posts Earnings in Q4, Revenues Top Estimates
Tandem Diabetes Care, Inc. (TNDM - Free Report) reported earnings per share of 2 cents in fourth-quarter 2018 compared with net loss of $1.23 posted in the year-ago period. The Zacks Consensus Estimate was pegged at a loss of 22 cents.
For the full year, the company registered loss of $2.55 per share, much narrower than the year-ago loss of $12.87 per share. The Zacks Consensus Estimate was pegged at a loss of $3.22 per share.
Revenues in Detail
Revenues in the quarter totaled $76.2 million, sailing past the Zacks Consensus Estimate by 34.9%. The top line also surged 89.1% from the year-ago quarter.
The roll-out of t:slim X2 with Basal-IQ technology, increased supply capacity and renewal sales, strengthening the company’s core business, along with its international launch, considerably drove top-line growth.
In the fourth quarter, Tandem Diabetes’ pump shipments soared 133% year over year to 16,168 pumps.Of these, 3,200 pumps were shipped to international markets. Accordingly, Tandem Diabetes recorded international sales of $7.1 million in the quarter.
...
https://www.zacks.com/stock/news/357149/...-estimates
![[Bild: TNDMc1dl1611.png]](https://finviz.com/publish/022719/TNDMc1dl1611.png)
Tandem Diabetes Care, Inc. (TNDM - Free Report) reported earnings per share of 2 cents in fourth-quarter 2018 compared with net loss of $1.23 posted in the year-ago period. The Zacks Consensus Estimate was pegged at a loss of 22 cents.
For the full year, the company registered loss of $2.55 per share, much narrower than the year-ago loss of $12.87 per share. The Zacks Consensus Estimate was pegged at a loss of $3.22 per share.
Revenues in Detail
Revenues in the quarter totaled $76.2 million, sailing past the Zacks Consensus Estimate by 34.9%. The top line also surged 89.1% from the year-ago quarter.
The roll-out of t:slim X2 with Basal-IQ technology, increased supply capacity and renewal sales, strengthening the company’s core business, along with its international launch, considerably drove top-line growth.
In the fourth quarter, Tandem Diabetes’ pump shipments soared 133% year over year to 16,168 pumps.Of these, 3,200 pumps were shipped to international markets. Accordingly, Tandem Diabetes recorded international sales of $7.1 million in the quarter.
...
https://www.zacks.com/stock/news/357149/...-estimates
__________________
